Balraj Kakkar

Partner & Managing Director, Parthenon-EY, Ernst & Young LLP

Balraj is a Partner in EY’s Life Sciences practice who brings with him 20+ years of experience in life sciences, healthcare and policy. 

Prior to joining EY, Balraj was a Managing Director with Navigant Consulting, a management consulting firm, where he supported global bio-pharmaceutical companies in developing portfolio and franchise strategies, organization re-design, M&A and licensing to enable the transition from a mass-market primary care business to a largely specialty business. He led teams that supported the successful launch of 10+ specialty products and helped clients expand their presence across multiple geographies (US, EU, Asia & Middle East). 

Most recently he worked on commercial model options and GTM strategies to prepare Life Sciences companies for changes in their product portfolio and the evolving healthcare ecosystem in the US. 

Before joining Navigant, Balraj worked at Bristol Myers Squibb where he held various roles in Business Development, Marketing and Market Research. 

 

Industry expertise: 

-Key sectors of the global life sciences industry
-Global Pharmaceuticals, Bio-Technology companies & Biosimilar/Generic manufacturers
-Medical Devices, Diagnostics & Digital Health companies
-Key sectors of the U.S. health care delivery system
-Payers (Commercial MCOs, Medicare Part D & Medicare Advantage plans, State Medicaid) 
-Intermediaries (PBMs, Specialty Pharmacy & Distributors) 
-Providers (Hospitals, Academic Centers, Integrated Health Systems) 


Select experiences: 
-Development and commercial strategies for the immuno-oncology portfolio of a leading bio-oncology company
-Disease area strategy and commercial model options for a global pharma re-entering the Anti-Infective market
-Heart Failure portfolio strategy for a global pharma with multiple assets in various stages of development
-Cardio-Metabolic-Renal disease area strategy for a leading bio-tech focusing on next-gen therapies
-Commercial strategies and launch preparation for blockbuster products in Multiple Sclerosis & Psoriasis
-Commercial due-diligence and valuation of a novel cell based therapy for rare hematological malignancies
-Evaluation of diagnostic and technology partnership models for the neuroscience franchise
-Assess impact of ACA on the payer mix and contracting strategy for a leading bio-pharmaceutical company


Fields of expertise: 
-Clinical development and commercial strategies, GTM and operating models, due diligence and M&A for the Life Sciences sector
-Organizational and commercial excellence to ensure success in a rapidly evolving healthcare ecosystem
-Core areas of expertise include market assessments, growth strategies, portfolio and disease area strategy, product launch, market access and diligence support
-Expertise across specialty diseases, oncology and rare-diseases


Education: 
Balraj earned a MS in Decision Sciences from Drexel University and a MBA from the Stern School of Business at New York University.